Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiman Jamshidi

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of the American College of Cardiology|February 27, 2016
Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and PredictorsSerban Puricel, Florim Cuculi, Melissa Weissner, et al.
JACC. Cardiovascular Interventions|March 18, 2014
Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation: immediate and intermediate-term resultsBahram Sohrabi, Peiman Jamshidi, Alireza Yaghoubi, et al.
American Heart Journal|September 1, 2014
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trialThomas Pilgrim, Marco Roffi, David Tüller, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 7, 2016
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trialAnna Franzone, Masanori Taniwaki, Fabio Rigamonti, et al.
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.
JACC. Cardiovascular Interventions|June 25, 2016
The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry MonitoringStefan Toggweiler, Stefan Stortecky, Erik Holy, et al.
Open Heart|October 22, 2014
Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcomeStefan Toggweiler, Michel Zuber, Daniel Sürder, et al.
Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of the American College of Cardiology|February 27, 2016
Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and PredictorsSerban Puricel, Florim Cuculi, Melissa Weissner, et al.
JACC. Cardiovascular Interventions|March 18, 2014
Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation: immediate and intermediate-term resultsBahram Sohrabi, Peiman Jamshidi, Alireza Yaghoubi, et al.
American Heart Journal|September 1, 2014
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trialThomas Pilgrim, Marco Roffi, David Tüller, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 7, 2016
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trialAnna Franzone, Masanori Taniwaki, Fabio Rigamonti, et al.
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.
JACC. Cardiovascular Interventions|June 25, 2016
The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry MonitoringStefan Toggweiler, Stefan Stortecky, Erik Holy, et al.
Open Heart|October 22, 2014
Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcomeStefan Toggweiler, Michel Zuber, Daniel Sürder, et al.
Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.
Pageof 6